Stay updated with breaking news from Mid Caps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press ReleaseNicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 Trial in Glaucoma Denali Phase 3 co-funded equally by Nicox and Ocumension TherapeuticsPhase
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Press ReleaseNicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical DevelopmentDecember 13, 2021- release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext